BioPharm International’s Biopharma Knowledge Resources Newsletter:
Having trouble viewing this e-mail? CLICK HERE
BioPharm
July 25, 2019
WEBSITE ARCHIVE SUBSCRIBE FORWARD
ADVERTISEMENT

In This Issue

Build your biopharma development and manufacturing knowledge base with the latest whitepapers, application notes, posters, and other educational resources from biopharma industry suppliers.

 Featured App Note

Bio-Inert HPLC Analysis of Nucleotides

Sonja Krieger, Agilent

Chromatographic separation of phosphorylated species, such as nucleotides, is highly challenging. Instrument and column inertness ensure successful analysis.

Process Development

Is Your In-House Strategy Ready for The Uncertainties of Biologic Drug Development?

John Ward, Vice President, Engineering, Thermo Fisher Scientific

The pharmaceutical industry’s past reliance on blockbuster drugs has evolved to include developing drugs that treat the needs of smaller patient populations. These drugs most often come in the form of biologics, which are an increasingly larger share of new drug approvals in the past decade, from 10 percent to 27 percent.

Quality

Early Product Characterization Mitigates Risks in Biologics Development

Daniel Galbraith, PhD, MilliporeSigma

What are the structural attributes of the drug? How does this drug function biologically? Learn how examination of product attributes using high resolution techniques answers critical questions early in drug development.

Downstream Processing

Antibody Drug Conjugate Purification Using TOYOPEARL® PPG-600M Resin

Tosoh Bioscience LLC

In this application note, antibody drug conjugates (ADCs) were separated into groups with low, medium, and high drug-to-antibody ratios (DARs) using TOYOPEARL PPG-600M resin with a three-step gradient.

magazine | Subscribe | Advertise | Contact Sales